HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The neuroprotective effects of Galectin-1 on Parkinson's Disease via regulation of Nrf2 expression.

AbstractOBJECTIVE:
Parkinson's disease (PD) is one of the neurodegenerative diseases. Galectin-1 (Gal-1) is expressed in the central nervous system. Our study sought to explore the neuroprotective effect of Gal-1 in 1‑methyl‑4‑phenyl pyridine ion (MPP+)-induced cytotoxicity on SH-SY5Y cells.
MATERIALS AND METHODS:
SH-SY5Y cells were cultured in vitro, pretreated with Gal-1, and then exposed to MPP+. Thereafter, the generation of reactive oxygen species (ROS) in SH-SY5Y cells was investigated. The effects of Gal-1 on DNA breakage, cell damage (release of lactate dehydrogenase (LDH)), viability, and apoptosis in SH-SY5Y cells were examined by comet assay, LDH assay, WST-1 assay, and flow cytometry, respectively. Additionally, the regulatory effect of Gal-1 on Nrf2 expression was examined by western blot. Zebrafish embryos were pretreated with Gal-1 and then exposed to MPP+. The locomotor ability of zebrafish larvae was then investigated.
RESULTS:
MPP+ induced the production of ROS in cells, which can be alleviated by pretreatment with Gal-1. Gal-1 protected cells from MPP+-induced cytotoxicity by preventing DNA breakage and cell injury. Gal-1 inhibited apoptosis in SH-SY5Y cells. The neuroprotective effect of Gal-1 could be abolished when Nrf2 expression knockdown. Moreover, exposure to MPP+ decreased the locomotor activity of zebrafish, which was attenuated by pretreatment with Gal-1.
CONCLUSIONS:
Our study demonstrated that the administration of Gal-1 could protect neurons from cellular stress by preventing apoptosis and eliminating ROS. Moreover, the neuroprotective effect of Gal-1 in neuronal cells could be related to the activation of Nrf2 expression. Therefore, Gal-1 could be a promising strategy for treating PD.
AuthorsH-B Liu, Q-Y Li, X-D Zhang, Y Shi, J-Y Li
JournalEuropean review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 26 Issue 2 Pg. 623-636 (Jan 2022) ISSN: 2284-0729 [Electronic] Italy
PMID35113438 (Publication Type: Journal Article)
Chemical References
  • Galectin 1
  • NF-E2-Related Factor 2
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • 1-Methyl-4-phenylpyridinium
Topics
  • 1-Methyl-4-phenylpyridinium (toxicity)
  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Survival
  • Galectin 1 (genetics, metabolism, pharmacology)
  • NF-E2-Related Factor 2 (metabolism)
  • Neuroprotective Agents (pharmacology)
  • Oxidative Stress
  • Parkinson Disease (drug therapy, genetics)
  • Reactive Oxygen Species (metabolism)
  • Zebrafish (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: